Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 CAD | +0.77% | -2.96% | 0.00% |
04-15 | RBC Capital Markets Gives Nutrien Outperform Rating, US$70 Price Target | MT |
04-01 | Itafos Continues the Process to Explore and Evaluate Various Strategic Alternatives | CI |
Sales 2022 | 593M 810M 47.38B | Sales 2023 | 466M 635M 37.18B | Capitalization | 188M 257M 15.04B |
---|---|---|---|---|---|
Net income 2022 | 115M 157M 9.18B | Net income 2023 | 3M 4.09M 240M | EV / Sales 2022 | 0.51 x |
Net Debt 2022 | 101M 138M 8.05B | Net Debt 2023 | 72.79M 99.35M 5.81B | EV / Sales 2023 | 0.56 x |
P/E ratio 2022 |
1.76
x | P/E ratio 2023 |
49.4
x | Employees | 417 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 31.93% |
1 day | +0.77% | ||
1 week | -2.96% | ||
Current month | -1.50% | ||
1 month | -1.50% | ||
3 months | -2.96% | ||
6 months | +4.80% |
Managers | Title | Age | Since |
---|---|---|---|
George Delaney
CEO | Chief Executive Officer | 63 | 05/02/17 |
Matthew O’Neill
DFI | Director of Finance/CFO | - | 10/08/22 |
Tim Vedder
COO | Chief Operating Officer | - | 11/01/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 30/08/21 | |
George Delaney
CEO | Chief Executive Officer | 63 | 05/02/17 |
Ronald Wilkinson
BRD | Director/Board Member | - | 11/01/18 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.31 | +0.77% | 56,216 |
25/04/24 | 1.3 | -1.52% | 67,100 |
24/04/24 | 1.32 | -2.22% | 129,200 |
23/04/24 | 1.35 | +2.27% | 129,353 |
22/04/24 | 1.32 | -2.22% | 29,693 |
Delayed Quote Toronto S.E., April 26, 2024 at 08:19 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 183M | |
+0.63% | 15.02B | |
-17.37% | 13.81B | |
+3.13% | 12.19B | |
-15.34% | 9.72B | |
-11.77% | 7.35B | |
-.--% | 7.31B | |
-5.39% | 6.35B | |
-5.54% | 4.18B | |
-28.77% | 2.37B |
- Stock Market
- Equities
- IFOS Stock